Infanrix hexa PSUR 19 (including PSUR 17, 18 & 19) GSK report to European Medicnes Agency (EMA)

23 October 2011 to 22 October 2014 dated 15 January 2015 obtained obtained by Dr Loretta Bolgan from the EMA under Article 3 of EMA rules and EMA policy on access to documents related to medicinal products for human and veterinary use (EMA 110196/2006 of 30 November 2010).

GlaxoSmithKline Biological clinical safety and pharmacovigilance’s confidential report to the EMA